Pfizer and BioNTech will submit an emergency use authorization request for their jointly-developed COVID-19 vaccine
Category: Markets
King Dollar Relinquishes Global Payments Crown. But Save Your ‘Demise’ Narratives
Those who love a good “dethroning King Dollar” story will be excited to know that
Don’t Worry: The Housing Bubble Is Alive And Well
At least the housing bubble is intact. Existing home sales defied expectations for a decline,
Jobless Claims Unexpectedly Rise, Adding To Economic Consternation
742,000 Americans filed for unemployment claims last week, more than the market expected. It’s an
Erdogan Lets New Central Bank Governor Hike Rates. U-Turn ‘Obviously’ Won’t Last
Warm congratulations to Naci Agbal, who replaced Murat Uysal at the helm of Turkey’s central
Slow Bleed
The dollar moved higher from a 29-month low Thursday, as risk-off vibes tied to America’s
Obligations Of The Undead
Meanwhile, from the world of “zombies” and possibly unsustainable debt burdens… The financial media (and
With Bitcoin 10 Times More Precious Than Gold, Ray Dalio Wonders If He’s ‘Missing Something’
“Investors” are flocking to Bitcoin as fears of currency debasement grow. That’s this week’s cryptocurrency
Vaccine Trade Bandwagon Jumpers Should Be Wary Of Calling Top On Tech Bubble
As the encouraging vaccine news piles up, one imagines the calls for a sustainable rotation
95% (And A Stocking Stuffer Idea)
Pfizer on Wednesday said its COVID-19 vaccine, jointly developed with BioNTech, is 95% effective according
The Vagaries Of Being Walmart In A Pandemic
Walmart, a company which knows a thing or two about the retail business, didn’t have
Macro Tourist: I’m Shorting Tesla On The Index Inclusion News
“Well, it finally happened.”
Market Close To ‘Full Bull,’ BofA Says
We’re close to “full bull,” BofA’s Michael Hartnett declared, in the latest edition of the
Retail Sales Stumbled In October, Which Isn’t Surprising Because People Are, You Know, Starving
Some will call it inevitable. US retail sales rose just 0.3% in October, less than
Nomura’s McElligott: Investors ‘Respect’ Potential For More Shocks. Complacency Not Currently An Issue
While the global equity rally looked poised to cool in the face of new virus
Pay No Attention To That Flaming Country
The latest wave of vaccine optimism receded a bit on Tuesday as the reality of
Diminishing Returns And WAM Chatter Galore
As expected, Monday’s encouraging vaccine news from Moderna prompted outperformance from value, small-caps, and other
Goldman On The Dollar: Depreciation To Extend Into 2021 – And ‘Possibly Well Beyond’
The broad, trade-weighted dollar will decline 6% over the next 12 months, Goldman says, in
Morgan Stanley: ‘Keep The Faith’ After ‘Super-Charged’ Global Economic ‘Take-Off’
“Keep the faith, trust the recovery” and buy stocks. That, in a nutshell, is the
Rotation On? Moderna Vaccine News May Presage Encore For Historic Factor Reversal
The reaction to Moderna’s encouraging COVID-19 vaccine data, released exactly a week after a similarly
‘A Pivotal Moment’
Global equities found quite a bit to like in trade news and economic data out
China’s Key October Data Is Good Enough. PBOC Moves To Quell Liquidity Concerns
China’s economic recovery remained largely on track in October, activity data out Monday suggested. Retail
New Week, Same Virus
Markets will kick off the new week confronted with more disconcerting news flow around the
Head-Fakes And One ‘Giant Logistical Project’
Some would probably tell you the dramatic rotation that played out in the equities space
Gather ‘Round Children, It’s Time For A Liquidity Ghost Story
“If Democrats take control of the Senate after the January 5th Georgia runoff elections, our
While You Were Watching The Election Soap Opera, Earnings Season Was ‘Stellar’
You may not have noticed, but Q3 earnings season went remarkably well. In fact, it
Investors Just Rushed Back Into Junk
Earlier this week, US junk bond yields hit all-time lows amid the rampant euphoria that
You must be logged in to post a comment.